SYNTHESIS OF ANTAGONISTS OF MUSCARINIC (M3) RECEPTORS

被引：2

作者：

Broadley, Kenneth J. ^{[3
]}

Davies, Robin H. ^{[2
]}

Escargueil, Christine ^{[3
]}

Lee, Alan T. L. ^{[1
]}

Penson, Peter ^{[3
]}

Thomas, Eric J. ^{[1
]}

机构：

[1] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England

[2] Muscagen Ltd, Cardiff CF10 3DFY, S Glam, Wales

[3] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3NB, S Glam, Wales

来源：

COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS | 2011年 / 76卷 / 07期

关键词：

Muscarinic receptors; Antagonists; Suzuki-Miyaura coupling; alpha-Hydroxyamides; Alcohols; Amides; Biological activity; Medicinal chemistry; HIGH SELECTIVITY; OXIDATION; ALDEHYDES; ALCOHOLS;

D O I：

10.1135/cccc2011017

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Several alpha-hydroxyamides with (2,6-dialkoxyphenoxy) methyl substituents have been prepared and their activities as antagonists of the M-3 muscarinic receptor in guinea pig ileum have been evaluated. N-{1-[(Phenyl)methyl]piperidin-4-yl}-2-{2-[(2,6-dimethoxyphenoxy)methyl]phenyl}-2-hydroxypropanamide and N-(1-[{6-amino-4-[(1-propylpiperidin-4-yl)methyl]pyridin-2-yl}methyl]piperidin-4-yl)-2-cyclopentyl-2-hydroxy-2-phenylacetamide were the most potent compounds prepared, the micromolar potency of the latter indicating that it may be worth further investigation.

引用

页码：781 / 801

页数：21

共 50 条

[31] Cystometric findings in mice lacking muscarinic M2 or M3 receptors
Igawa, Y
Zhang, XY
Nishizawa, O
Umeda, M
Iwata, A
Taketo, MM
Manabe, T
Matsui, M
Andersson, KE
JOURNAL OF UROLOGY, 2004, 172 (06): : 2460 - 2464
[32] Differences in sensitivity to local anesthetics of muscarinic m1 and m3 receptors
Ritter, CH
Hollmann, MW
Durieux, ME
ANESTHESIOLOGY, 2000, 93 (3A) : U196 - U196
[33] Voltage sensitivity of muscarinic M1, M3 and M5 receptors
Rinne, A.
Buenemann, M.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S66 - S66
[34] EFFECTS OF ENANTIOMERS OF M(3) ANTAGONISTS ON MUSCARINIC RECEPTORS IN RABBIT TRACHEA
LOENDERS, B
RAMPART, M
HERMAN, AG
ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1994, 328 (02): : 225 - 234
[35] Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
Liu, Hongtao
Hofmann, Josefa
Fish, Inbar
Schaake, Benjamin
Eitel, Katrin
Bartuschat, Amelie
Kaindl, Jonas
Rampp, Hannelore
Banerjee, Ashutosh
Huebner, Harald
Clark, Mary J.
Vincent, Sandra G.
Fisher, John T.
Heinrich, Markus R.
Hirata, Kunio
Liu, Xiangyu
Sunahara, Roger K.
Shoichet, Brian K.
Kobilka, Brian K.
Gmeiner, Peter
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (47) : 12046 - 12050
[36] Pfizer's dual-acting β2 agonists/muscarinic M3 antagonists
Norman, Peter
EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (09) : 1091 - 1096
[37] Alteration of M3 subtype muscarinic receptors in the diabetic rat urinary bladder
Tong, YC
Cheng, JT
PHARMACOLOGY, 2002, 64 (03) : 148 - 151
[38] Differential expression of M3 muscarinic receptors in progressive colon neoplasia and metastasis
Cheng, Kunrong
Shang, Aaron C.
Drachenberg, Cinthia B.
Zhan, Min
Raufman, Jean-Pierre
ONCOTARGET, 2017, 8 (13) : 21106 - 21114
[39] Contractions of the Mouse Prostate Elicited by Acetylcholine Are Mediated by M3 Muscarinic Receptors
White, Carl W.
Short, Jennifer L.
Haynes, John M.
Matsui, Minoru
Ventura, Sabatino
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (03): : 870 - 877
[40] MUSCARINIC M3 RECEPTORS MEDIATE SECRETION FROM SWEAT GLANDS IN THE RAT
SCHIAVONE, A
BRAMBILLA, A
PHARMACOLOGICAL RESEARCH, 1991, 23 (03) : 233 - 239

← 1 2 3 4 5 →